Immunoblot analyses showed that ERK1/2 phosphorylation was markedly decreased in the WT tumor-bearing mice over-expressing SAP18 and increased in CXCR2−/− tumor-bearing mice treated with the SAP18 knock down (Fig. 6e and Fig. S7C). Here, MAPK3 is linked to neoplasm.